Current Oncology (Feb 2022)

Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review

  • Nikolaos Kalampokis,
  • Nikolaos Grivas,
  • Markos Karavitakis,
  • Ioannis Leotsakos,
  • Ioannis Katafigiotis,
  • Marcio Covas Moschovas,
  • Henk van der Poel,
  • European Association of Urology (EAU) Young Academic Urologists (YAU) Robotic Urology Working Group

DOI
https://doi.org/10.3390/curroncol29030111
Journal volume & issue
Vol. 29, no. 3
pp. 1309 – 1315

Abstract

Read online

(1) Background: Following radical prostatectomy (RP), the absence of a demonstrable tumor on the specimen of a previously histologically proven malignancy is known as the pT0 stage. The aim of our present study is to perform a narrative review of current literature in order to determine the frequency and oncological outcomes in patients with pT0 disease. (2) Methods: A narrative review of all available literature was performed. (3) Results: The incidence of pT0 ranges between 0.07% and 1.3%. Predictors of the pT0 stage are only a single biopsy core with low-grade cancer, a cancer length not exceeding 2 mm and a high prostate volume. Biochemical recurrence ranges between 0 and 11%. (4) Conclusions: The absence of malignancy in the RP specimen despite a previous positive biopsy is a rare and unpredictable finding. Although the prognosis is considered to be excellent in most of the cases, a continued close follow-up is warranted.

Keywords